Evidence map›Paper›PMID 32284067›Full record

ArticleLipids in health and disease2020

Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort.

Emin Grbić, Nataša Gorkič, Aleš Pleskovič, Marjeta Zorc, Farid Ljuca, Mladen Gasparini, Božidar Mrđa, Ines Cilenšek, Sara Mankoč, Maciej Banach and 2 more

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Emin GrbićDepartment of Physiology, Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Nataša GorkičInternational Center for Cardiovascular Diseases MC Medicor d.d, Izola, Slovenia.
Aleš PleskovičDepartment of Cardiology, Division of Medicine, University Medical Centre of Ljubljana, Ljubljana, Slovenia.
Marjeta ZorcInternational Center for Cardiovascular Diseases MC Medicor d.d, Izola, Slovenia.
Farid LjucaDepartment of Physiology, Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Mladen GaspariniDepartment of Vascular Surgery, General Hospital Izola, Izola, Slovenia.
Božidar MrđaDepartment of Vascular Surgery, University Medical Centre Maribor, Maribor, Slovenia.
Ines CilenšekInstitute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000, Ljubljana, Slovenia.
Sara MankočInstitute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000, Ljubljana, Slovenia.
Maciej BanachCardiovascular Research Centre, University of Zielona-Gora, Zielona Gora, Poland.
Daniel PetrovičInternational Center for Cardiovascular Diseases MC Medicor d.d, Izola, Slovenia. daniel.petrovic@mf.uni-lj.si.
Zlatko FrasDepartment of Cardiology, Division of Medicine, University Medical Centre of Ljubljana, Ljubljana, Slovenia. zlatkofras63@gmail.com.
University of Ljubljana · SILjubljana University Medical Centre · SIUniversity of Tuzla · BAIzola General Hospital · SIPolish Mother’s Memorial Hospital Research Institute · PLUniversity Clinical Centre Maribor · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHistone deacetylase 9 (HDAC9) plays an important role in transcriptional regulation, cell cycle progression and developmental events; moreover, it has been investigated as a candidate gene in a number of conditions, including the onset and progression of atherosclerosis. We hypothesized that the rs2107595 HDAC9 gene polymorphism may be associated with advanced carotid artery disease in a Slovenian cohort. We also investigated the effect of this polymorphism on HDAC9 receptor expression in the internal carotid artery (ICA) specimens obtained by endarterectomy.

methodsThis case-control study enrolled 619 unrelated Slovenian patients: 311 patients with ICA stenosis > 75% as the study group and 308 patients with ICA stenosis < 50% as the control group. Patient laboratory and clinical data were obtained from the medical records. The rs2107595 polymorphisms were genotyped using TaqMan SNP Genotyping assay. HDAC9 expression was assessed by immunohistochemistry in 30 ICA specimens from patients with ICA atherosclerosis > 75%, and the numerical areal density of HDAC9 positive cells was calculated.

resultsThe occurrence of advanced ICA atherosclerosis in the Slovenian cohort was 3.81 times higher in the codominant genetic model (OR = 3.81, 95%CI = 1.06-13.77, p = 0.04), and 3.10 times higher in the recessive genetic model (OR = 3.10, 95%CI = 1.16-8.27, p = 0.02). In addition, the A allele of rs2107595 was associated with increased HDAC9 expression in the ICA specimens obtained by endarterectomy.

conclusionsWe observed a significant association between the AA genotype of rs2107595 with the advanced carotid artery disease in our Slovenian cohort, indicating that this polymorphism may be a genetic risk factor for ICA atherosclerosis.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAgedAllelesCarotid Artery DiseasesCase-Control StudiesCohort StudiesHistone DeacetylasesHumansLogistic ModelsMiddle AgedPolymorphism, Single NucleotideRepressor ProteinsSloveniaHDAC9 protein, humanHistone DeacetylasesRepressor ProteinsAdvanced carotid atherosclerosisAtherosclerosisCarotid atherosclerosisHistone deacetylase 9 (HDAC9) gene polymorphism

Identifiers

PMID32284067
PMCPMC7155263
OpenAlexW3015449874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.